Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 4Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 20Lymphoma, Large B-Cell, Diffuse 16Lymphoma 14Neoplasms 13Sarcoma 10Hodgkin Disease 10Triple Negative Breast Neoplasms 9Lymphoma, Follicular 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, B-Cell 7Ovarian Neoplasms 6Burkitt Lymphoma 6Lymphoma, Non-Hodgkin 5Fallopian Tube Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Sarcoma, Ewing 3Recurrence 3Leiomyosarcoma 3Inflammatory Breast Neoplasms 3Endometrial Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Sarcoma, Synovial 2Rhabdomyosarcoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neurofibrosarcoma 2Neuroblastoma 2Lymphoproliferative Disorders 2Lymphoma, Mantle-Cell 2

Interventions

Specimen Handling 4Nivolumab 4avelumab 3pembrolizumab 2cabozantinib 2atezolizumab 2Magnetic Resonance Spectroscopy 2Ipilimumab 2Immunoglobulin G 2Gemcitabine 2Disulfides 2Cisplatin 2CTLA-4 Antigen 2Biopsy 2tremelimumab 1tocilizumab 1relatlimab 1guadecitabine 1eribulin 1erdafitinib 1enfortumab vedotin 1durvalumab 1Propranolol 1Platinum 1Leucovorin 1Fluorouracil 1Etoposide 1Doxorubicin 1Docetaxel 1Contrast Media 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Urethral Neoplasms × Doxorubicin × Clear all
NCT00479128 2026-04-16

Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
80 enrolled
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡